15don MSN
The framework cleared the House in a 217–215 vote, paving the way for the GOP to unlock the legislative process and begin drafting Trump’s marquee agenda.
This post contains affiliate links, where we may receive a percentage of any sale made from the links on this page. Prices and availability are accurate as of the time of publication. Every major ...
The FDA has turned down Blueprint Medicines’ Ayvakit for more ... and the agency decided it wanted to see the results of an ongoing phase 3 trial comparing Ayvakit to Bayer’s Stivarga ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results